Skip to main content
STAA
NASDAQ Industrial Applications And Services

STAAR Surgical ends interim leadership, names Warren Foust permanent CEO with options tied to a more than doubling of the stock price

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$22.89
Mkt Cap
$1.14B
52W Low
$15.585
52W High
$35.87
52W Position info
47% above low
Off High info
36% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

STAA sits 47% above its 52-week low of $15.585 on light trading volume (0.2× avg).

Summary

STAAR Surgical appointed Warren Foust as permanent CEO and granted him performance options that vest only if the stock reaches $50, $75, or $100—more than double today's price. CFO Deborah Andrews was promoted to EVP.


Key Events · Executive and Board Changes · STAA

  • CEO Appointment Finalized

    Warren Foust, who served as Interim Co-CEO since February 2026, was appointed permanent President and CEO effective August 4, 2026, ending a six-month leadership transition.

  • Performance-Linked Equity Grant

    Foust received 395,494 performance-vesting options that vest only if STAAR's 60-day VWAP reaches $50, $75, or $100—more than double the current $22.89 price—plus 67,479 RSUs and 121,413 time-vesting options.

  • CFO Promotion

    Deborah Andrews, who served as Interim Co-CEO alongside Foust, was appointed Executive Vice President and will continue as CFO, receiving 4,975 RSUs and 38,111 options (including 29,159 performance-based).

  • High Bar for Shareholder Value

    The performance options require the stock to more than double before any shares vest, aligning management incentives with a significant recovery from the recent 12% post-earnings drop.


Analysis · STAA · Industrial Applications And Services

After a six-month interim period, STAAR Surgical appoints Warren Foust as permanent CEO, closing the leadership gap. His compensation package heavily weights equity toward performance options that require the stock to reach $50, $75, or $100—more than double the current $22.89 share price—directly aligning his incentives with a dramatic recovery. The board also promotes CFO Deborah Andrews to EVP, underscoring confidence in the team that delivered record first-half results. While the performance options create potential dilution, they only kick in if the stock more than doubles, setting a high-water mark for shareholder value creation.

At the time of this filing, STAA was trading at $22.89 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $15.59 to $35.87. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

STAA - Latest Insights

STAA
Jul 16, 2026, 6:04 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
STAA
Jul 16, 2026, 4:01 PM EDT
Source: BusinessWire
Importance Score:
8
STAA
Jun 22, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
STAA
May 13, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
STAA
May 13, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
9